Bank of New York Mellon’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-26,335
| Closed | -$7K | – | 4418 |
|
|
2018
Q1 | $7K | Buy |
+26,335
| New | +$7K | ﹤0.01% | 4287 |
|
|
2017
Q4 | – | Sell |
-25,029
| Closed | -$10K | – | 4475 |
|
|
2017
Q3 | $10K | Buy |
+25,029
| New | +$10K | ﹤0.01% | 4242 |
|
|
2016
Q4 | – | Sell |
-2,259
| Closed | -$10K | – | 4396 |
|
|
2016
Q3 | $10K | Sell |
2,259
-863
| -28% | -$3.82K | ﹤0.01% | 4247 |
|
|
2016
Q2 | $28K | Buy |
3,122
+588
| +23% | +$5.27K | ﹤0.01% | 4245 |
|
|
2016
Q1 | $29K | Hold |
2,534
| – | – | ﹤0.01% | 4147 |
|
|
2015
Q4 | $36K | Hold |
2,534
| – | – | ﹤0.01% | 4190 |
|
|
2015
Q3 | $43K | Hold |
2,534
| – | – | ﹤0.01% | 4210 |
|
|
2015
Q2 | $48K | Buy |
2,534
+234
| +10% | +$4.43K | ﹤0.01% | 4157 |
|
|
2015
Q1 | $45K | Hold |
2,300
| – | – | ﹤0.01% | 4141 |
|
|
2014
Q4 | $67K | Hold |
2,300
| – | – | ﹤0.01% | 4105 |
|
|
2014
Q3 | $82K | Hold |
2,300
| – | – | ﹤0.01% | 4085 |
|
|
2014
Q2 | $103K | Buy |
2,300
+11
| +0.5% | +$493 | ﹤0.01% | 3985 |
|
|
2014
Q1 | $112K | Hold |
2,289
| – | – | ﹤0.01% | 3941 |
|
|
2013
Q4 | $85K | Hold |
2,289
| – | – | ﹤0.01% | 3990 |
|
|
2013
Q3 | $235K | Hold |
2,289
| – | – | ﹤0.01% | 3729 |
|
|
2013
Q2 | $178K | Buy |
+2,289
| New | +$178K | ﹤0.01% | 3780 |
|